News

Pfizer claimed that for the first time, clinicians can make direct contact through the Epocrates drug reference app on their iPhone device to pharmaceutical manufacturers and immediately apply

Scientia Advisors has released a review report titled ‘Assessing the Biopharmaceutical Market: Promises and Challenges.’ According to it the revenue growth for the small molecule drug segment has

Reportedly, the Phase III study results released by Vifor Pharma and Roche reached the primary endpoint of delaying treatment failure in patients with lupus nephritis who had successfully

Novella Clinical and Prologue Research have been providing contract research services for biotechnology, pharmaceutical and device companies for 12 years. The acquisition will add approximately 60 staff to

BD Diagnostics said that the BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer walkaway automation to accommodate varying workloads

The VitaVasK study will last for three years and will measure placebo controlled effect of high doses of MenaQ7 in some 600 kidney patients over one and a

The Weizmann and Niigata patents cover the use of transglutaminase inhibitors, a class of molecules chemically similar to Cysteamine, in the potential treatment of Huntington’s Disease and other

BLS has acquired the US and Canadian rights to commercialise products containing istradefylline, a new chemical entity targeted for the treatment of Parkinson’s disease. As per the terms

Advair contains fluticasone and salmeterol. Fluticasone is a steroid. Advair prevents the release of substances in the body that cause inflammation. Salmeterol is a bronchodilator. It works by